Readmission and mortality in malnourished, older, hospitalized adults treated with a specialized oral nutritional supplement: A randomized clinical trial
Deutz NE, Matheson EM, Matarese LE, Luo M, Baggs GE, Nelson JL, Hegazi RA, Tappenden KA, Ziegler TR
Published in Clinical Nutrition, Vol. 35 (1), pp. 18-26
Methodology
Randomised, double-blind, placebo-controlled trial of a high-protein oral nutritional supplement containing HMB in 652 malnourished hospitalised older adults
Key Findings
Ninety-day mortality was significantly lower with the HMB-containing supplement (4.8% vs 9.7%), although the primary composite of readmission or death was unchanged.
Conclusions
HMB-containing nutritional support reduced mortality in malnourished hospitalised older adults.
Limitations
Multi-nutrient supplement; HMB effect cannot be isolated; industry sponsored.
Supplements Studied
Ninety-day mortality was significantly lower with the HMB-containing supplement (4.8% vs 9.7%).
Outcomes Measured
Ninety-day mortality was significantly lower with the HMB-containing supplement (4.8% vs 9.7%).
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.